370 related articles for article (PubMed ID: 11661914)
1. Protecting human research subjects and the public: the role of FDA disqualification of clinical investigators.
Nightingale SL
Food Drug Cosmet Law J; 1980 Sep; 35(9):484-92. PubMed ID: 11661914
[No Abstract] [Full Text] [Related]
2. The regulation of clinical investigators.
Endries RN
Food Drug Cosmet Law J; 1980 Jul; 35(7):415-23. PubMed ID: 11661860
[No Abstract] [Full Text] [Related]
3. Data audit by a regulatory agency: its effect and implication for others.
Shapiro MF
Account Res; 1992; 2(3):219-29. PubMed ID: 11653981
[No Abstract] [Full Text] [Related]
4. Criminal liability for misconduct in scientific research.
Kuzma SM
Univ Mich J Law Reform; 1992; 25(2):357-421. PubMed ID: 11651584
[No Abstract] [Full Text] [Related]
5. Scientific misconduct: undue process.
Efron R
Account Res; 1993; 3(2-3):223-38. PubMed ID: 11652297
[No Abstract] [Full Text] [Related]
6. The ethics of conducting psychosis-inducing experiments.
Sharav VH
Account Res; 1999; 7(2-4):137-67. PubMed ID: 11658172
[No Abstract] [Full Text] [Related]
7. Rules to protect drug-test participants via follow-up exams are slated by FDA.
Spivak J
Wall St J (East Ed); 1976 Mar; ():5. PubMed ID: 11649042
[No Abstract] [Full Text] [Related]
8. A look at the bioresearch monitoring program: the agency perspective.
Brisson EL
Food Drug Cosmet Law J; 1983 Apr; 38(2):184-9. PubMed ID: 11649578
[No Abstract] [Full Text] [Related]
9. Military medical research: 1. Are there ethical exceptions?
Levine C
IRB; 1989; 11(4):5-7. PubMed ID: 11650244
[No Abstract] [Full Text] [Related]
10. Military medical research: 2. Proving the safety and effectiveness of a nerve gas antidote -- a legal view.
Cooper RM
IRB; 1989; 11(4):7-9. PubMed ID: 11650245
[No Abstract] [Full Text] [Related]
11. AIDS treatment drugs: clinical trials and compassionate use.
Levine RJ
AIDS Public Policy J; 1987; 2(2):6-8. PubMed ID: 11650031
[No Abstract] [Full Text] [Related]
12. Mandating research with children.
Baylis F
IRB; 1999; 21(1):10-1. PubMed ID: 11657966
[No Abstract] [Full Text] [Related]
13. Perspectives on the FDA status of drug products manufactured by the recombinant DNA technique.
Korwek EL; Trinker DS
Food Drug Cosmet Law J; 1981 Oct; 36(10):517-35. PubMed ID: 11650658
[No Abstract] [Full Text] [Related]
14. FDA treatment use regulations: a compassionate response.
Weitzman SA; Marcy T
AIDS Public Policy J; 1987; 2(2):22-32. PubMed ID: 11650028
[No Abstract] [Full Text] [Related]
15. Bioethics and applied biomaterials.
Saha S; Saha P
J Biomed Mater Res; 1987 Aug; 21(Suppl. A2):181-90. PubMed ID: 11649924
[No Abstract] [Full Text] [Related]
16. HHS publishes final debarment regulations.
Levine C
IRB; 1980 Nov; 2(9):10. PubMed ID: 11661885
[No Abstract] [Full Text] [Related]
17. Medical and psychological experimentation on California prisoners.
Herch F; Flower R
Univ Calif Davis Law Rev; 1974; 7():351-84. PubMed ID: 11661107
[No Abstract] [Full Text] [Related]
18. Reflections on the FDA's intraocular lens regulations.
Worthen DM
IRB; 1980 Apr; 2(4):1-3. PubMed ID: 11661783
[No Abstract] [Full Text] [Related]
19. Regulation of clinical research: who's protecting who from what?
Petricciani JC
Food Drug Cosmet Law J; 1979 Apr; 34(4):205-7. PubMed ID: 11661718
[No Abstract] [Full Text] [Related]
20. Fraud and misrepresentation in research--whose rights?
Schmaus W; Wigodsky HS
IRB; 1984; 6(5):10-1. PubMed ID: 11650663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
